Get the Stockscreener App
240.47
2.75%
6.4348
Vaneck Biotech Etf stock is traded at $240.47, with a volume of 10,884.
It is up +2.75% in the last 24 hours and up +4.00% over the past month.
See More
Previous Close:
$234.03
Open:
$234.08
24h Volume:
10,884
Relative Volume:
0.94
Market Cap:
$480.09M
Revenue:
Net Income/Loss:
P/E Ratio:
-
EPS:
-
Net Cash Flow:
1W Performance:
+1.27%
1M Performance:
+4.00%
6M Performance:
+26.85%
1Y Performance:
+37.65%
1-Day Range:
$234.08
$240.47
1-Week Range:
$230.25
$243.69
52-Week Range:
$171.63
$246.55
Vaneck Biotech Etf Stock (BBH) Company Profile
Name
Vaneck Biotech Etf
Sector
Industry
Phone
-
Address
-
Compare BBH vs VOO, IVV, SPY, VTI, QQQ
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BBH
Vaneck Biotech Etf
|
240.47 | 480.09M | 0 | 0 | 0 | 0.00 |
VOO
Vanguard S P 500 Etf
|
715.59 | 1.06T | 0 | 0 | 0 | 0.00 |
IVV
Ishares Core S P 500 Etf
|
781.97 | 898.64B | 0 | 0 | 0 | 0.00 |
SPY
Spdr S P 500 Etf Trust
|
778.57 | 833.41B | 0 | 0 | 0 | 0.00 |
VTI
Vanguard Total Stock Market Etf
|
381.94 | 697.19B | 0 | 0 | 0 | 0.00 |
QQQ
Invesco Qqq Trust Series 1
|
751.27 | 506.81B | 0 | 0 | 0 | 0.00 |
Vaneck Biotech Etf Stock (BBH) Latest News
VEFU ETF Holdings List — HAN:VEFU - tradingview.com
VEFU ETF Profile: Dividends, Returns (HAN:VEFU) - tradingview.com
VEFU ETF Price and Chart — HAN:VEFU - tradingview.com
Fidelity Healthcare ETF (FHLC) vs. VanEck Biotech ETF (BBH): Which Fund Is the Better Buy? - The Motley Fool
Fidelity Healthcare ETF (FHLC) vs. VanEck Biotech ETF (BBH): Which Fund Is the Better Buy? - The Globe and Mail
Fidelity Healthcare ETF (FHLC) vs. VanEck Biotech ETF (BBH): Which Fund Is the Better Buy? - The Globe and Mail
Fidelity Healthcare ETF (FHLC) vs. VanEck Biotech ETF (BBH): Which Fund Is the Better Buy? - The Globe and Mail
Biotech ETFs to Buy as Cancer Drug Breakthroughs Accelerate - Zacks Investment Research
Biotech ETFs to Buy as Cancer Drug Breakthroughs Accelerate - TradingView
Biotech ETFs to Buy as Cancer Drug Breakthroughs Accelerate - TradingView
Should You Invest in the VanEck Biotech ETF (BBH)? - Yahoo Finance
VanEck Pharmaceutical ETF vs VanEck Biotech ETF: Which Fund Is Better for Drug Innovation Profits? - The Motley Fool
VanEck Pharmaceutical ETF vs VanEck Biotech ETF: Which Fund Is Better for Drug Innovation Profits? - aol.com
VanEck Pharmaceutical ETF vs VanEck Biotech ETF: Which Fund Is Better for Drug Innovation Profits? - The Globe and Mail
Steak 'n Shake Bitcoin Bonus Offers Hourly Workers $438 Annually With Two-Year Wait - Yellow.com
Steak 'n Shake Bitcoin Bonus Offers Hourly Workers $438 Annually With Two-Year Wait - yellow.com
7 Best Biotech ETFs to Buy Now | Investing - US News Money
Steak 'n Shake Reports 19% Same-Store Sales Growth After Adopting Bitcoin Payments - finance.biggo.com
(BH) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Trading Systems Reacting to (BH.A) Volatility - Stock Traders Daily
Should You Invest in the VanEck Biotech ETF (BBH)? - Eastern Progress
Biglari Holdings Inc (BH) Shares Surge 3.0% -- What GF Score of 54 Tells Investors - GuruFocus
Steak ‘n Shake’s MAGA Makeover Is Winning Fans but Its Stock Is Complicated - Barron's
Steak 'n Shake Declares Itself a Bitcoin Company After 13.8% Same-Store Sales Surge - finance.biggo.com
Why a Famous Burger Chain Now Calls Itself a ‘Bitcoin Company’ - Cryptonews.net
Behavioral Patterns of BH and Institutional Flows - Stock Traders Daily
How to Choose Between Two Major Pharmaceutical Themed ETFs? - nai500.com
Which Healthcare ETF Offers the Better Growth Outlook: VanEck Biotech or Invesco Pharmaceuticals? - The Motley Fool
Biglari Sardar Makes New $8.30 Million Investment in El Pollo Loco Holdings, Inc. $LOCO - MarketBeat
Which Healthcare ETF Offers the Better Growth Outlook: VanEck Biotech or Invesco Pharmaceuticals? - Yahoo Finance
Biglari Sardar Buys New Position in Coca-Cola Consolidated, Inc. $COKE - MarketBeat
VanEck Biotech ETF (BBH) is a Buy with strong g... - Pluang
BBH: Biotech’s Next Growth Cycle Is Just Getting Started (NASDAQ:BBH) - Seeking Alpha
Biglari (BH) Results at a Glance: The Report Provides a New Financial Snapshot at the Close; Trading Move: Shares Finish 0.52% Down in the Latest SessionProfit Recovery Report - vinanet.vn
Which Biotech ETF Is a Better Buy: Concentrated Bet or Broad Basket? - The Motley Fool
The Zacks Analyst Blog Highlights Amgen, Crinetics, FBT, BBH and BBP - Eastern Progress
In Healthcare ETFs, Is iShares Pharma a Better Buy Than VanEck Biotech? - The Motley Fool
Bet on These Biotech ETFs as Innovation Drives Market-Beating Growth - TradingView
In Healthcare ETFs, Is iShares Pharma a Better Buy Than VanEck Biotech? - Yahoo Finance
Bet on These Biotech ETFs as Innovation Drives Market-Beating Growth - Eastern Progress
Healthcare ETFs Are Looking Up: Here's Why - TradingView
Which Healthcare ETF Is the Better Buy: VanEck's Pharma PPH or State Street's Biotech XBI? - sharewise.com
These 2 Stocks Are Setting Off Technical Alarm Bells with $1,000+ Price Tags. Here’s the Company I’d Bet on for the Long Term. - Barchart.com
Biglari (NYSE:BH) Sees Strong Trading VolumeShould You Buy? - MarketBeat
Which Healthcare ETF Is the Better Buy: VanEck's Pharma PPH or State Street's Biotech XBI? - The Globe and Mail
Which Healthcare ETF Is the Better Buy: VanEck's Pharma PPH or State Street's Biotech XBI? - The Motley Fool
These 2 Stocks Are Setting Off Technical Alarm Bells with $1,000+ Price Tags. Here’s the Company I’d Bet on for the Long Term. - Yahoo Finance
Discipline and Rules-Based Execution in BH.A Response - Stock Traders Daily
Biglari Holdings (BH) Slips 0.81% as Shares Test Key Support ZoneTWAP Entry - dars.gov.et
Biglari Holdings (BH) Slips 0.81% as Shares Test Key Support ZoneVolume Nodes - vinanet.vn
Vaneck Biotech Etf Stock (BBH) Financials Data
There is no financial data for Vaneck Biotech Etf (BBH). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.47%
0.13%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):